Laryngeal Nocardia: A Case Report.

LaryngoscopeJul 20, 2026 (epub)

Olivia Singleton, Grant Owen, Emily Wright et al.

✦ AI-curated · Sources linked

Case in brief

An immunosuppressed patient presented with an obstructive laryngeal mass, for which malignancy was a key diagnostic consideration. Biopsy findings did not suggest malignancy, and the case was diagnosed as laryngeal nocardiosis. The report highlights an infectious cause of an obstructive laryngeal lesion and emphasizes that considering infection in the differential may help avoid delayed treatment and airway compromise.

What made this case unusual

Laryngeal nocardiosis presented as an obstructive mass in an immunosuppressed patient, mimicking a lesion for which malignancy would commonly be considered.

Diagnostic / clinical pearl

An obstructive laryngeal mass in an immunosuppressed patient is not necessarily malignant; infectious etiologies should remain in the differential, particularly when biopsy does not support malignancy.

Why it matters

The authors note that earlier consideration of infection may reduce treatment delays, airway compromise, and mortality.

Source

Published in Laryngoscope. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Otolaryngology (ENT)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.